Jingdong Zhang
Jingdong Zhang (June 2, 1968 – January 09, 2020) was a Chinese–Danish chemist and Professor of Chemistry at the Technical University of Denmark. Her research considered nanochemistry and the novel materials for catalysis, as well as the development of advanced characterisation techniques such as scanning tunnelling microscopy and atomic force microscopy. She was elected to the Akademiet for de Tekniske Videnskaber in 2017. Provided by Wikipedia
Showing 1 - 18 results of 18 for search 'Jingdong Zhang', query time: 0.03s
Refine Results
-
1
-
2
A Novel Depression Risk Prediction Model Using NHANES Data With Mendelian Randomization Validation by Lin Lin, Liqun Zhang, Jingdong Zhang, Dapeng Ding
Published 2025-07-01Get full text
Article -
3
-
4
Domestication and feedback: bidirectional hijacking in pancreatic ductal adenocarcinoma microenvironment by Yuxi Qiao, Haobo Yin, Yong Zhang, Jingdong Zhang, Qian Dong
Published 2025-08-01Get full text
Article -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Concurrent presentation of proliferative glomerulonephritis with monoclonal immunoglobulin deposits and light chain proximal tubulopathy: a case report and review of the literature by Jingdong Zhang, Yang Liu, Fengyan Jin, Jia Li, Hui Wang, Fuzhe Ma, Ye Jia, Jinyu Yu, Shan Wu, Shaojie Fu, Zhonggao Xu, Hao Wu
Published 2025-01-01Get full text
Article -
16
A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021 by Hong Zhao, Yilei Mao, Hongguang Wang, Aiping Zhou, Zhengqiang Yang, Yue Han, Gong Li, Xinyu Bi, Chunyi Hao, Xiaodong Wang, Jun Zhou, Chaoliu Dai, Feng Wen, Jingdong Zhang, Ruibao Liu, Tao Li, Lei Zhao, Zuoxing Niu, Tianfu Wen, Qiu Li, Hongmei Zhang, Xiaoming Chen, Minshan Chen, Ming Zhao, Yajin Chen, Jun Yu, Jie Shen, Xiangchen Li, Lianxin Liu, Zhiyong Huang, Wei Zhang, Feng Shen, Weiping Zhou, Zhengang Yuan, Jian Zhai, Ningling Ge, Yongjun Chen, Huichuan Sun, Jianqiang Cai
Published 2025-06-01Get full text
Article -
17
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation by Dan-Yun Ruan, Hao-Xiang Wu, Ye Xu, Pamela N. Munster, Yanhong Deng, Gary Richardson, Dong Yan, Myung-Ah Lee, Keun-Wook Lee, Hongming Pan, Steven Hager, Xingya Li, Shaozhong Wei, Xinfang Hou, Craig Underhill, Michael Millward, Ina Nordman, Jingdong Zhang, Jianzhen Shan, Guohong Han, Jaspreet Grewal, Shirish M. Gadgeel, Rachel E. Sanborn, Seok Jae Huh, Xiaohua Hu, Yihong Zhang, Ziyong Xiang, Laisheng Luo, Xiaoxi Xie, Zhe Shi, Yaolin Wang, Ling Zhang, Feng Wang, Rui-Hua Xu
Published 2025-06-01Get full text
Article -
18
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial by Chuanhua Zhao, Yanqiao Zhang, Gang Wang, Jinfang Zheng, Weiqing Chen, Zheng Lu, Li Zhuang, Shanzhi Gu, Lei Han, Zhendong Zheng, Zujiang Yu, Yongsheng Yang, Hongmei Sun, Xiaoyong Wei, Ying Cheng, Hailan Lin, Bo Zhu, Guicheng Wu, Kaijian Lei, Wei Wang, Yuwen Wang, Kehe Chen, Ximing Xu, Cuiping Zheng, Yanzhi Bi, Sijuan Ding, Jingdong Zhang, Wei Li, Hailong Liu, Jun Wang, Xianling Liu, Yangfeng Du, Lianming Cai, Jingran Wang, Zhanxiong Luo, Baocai Xing, Jie Shen, Lin Yang, Jianbing Wu, Ou Jiang, Zhigang Peng, Xiuli Liu, Bangwei Cao, Liangfang Shen, Aibing Xu, Aimin Li, Shaojun Chen, Ting Fu, Jian Chen, Chuan Jin, Lei Zhang, Jun Lv, Chengwu Zhang, Xiaoman Zhang, Yu Wang, Huo Su, Qiang Zhou, Wenlin Gai, Liangzhi Xie, Jianming Xu
Published 2025-08-01Get full text
Article